相似文献
1
mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation.
Curr Allergy Asthma Rep. 2023 Mar;23(3):195-200. doi: 10.1007/s11882-023-01065-2. Epub 2023 Jan 23.
2
Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
Ann Allergy Asthma Immunol. 2022 Feb;128(2):161-168.e1. doi: 10.1016/j.anai.2021.10.019. Epub 2021 Oct 24.
3
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.
4
COVID-19 mRNA vaccine allergy.
Curr Opin Pediatr. 2021 Dec 1;33(6):610-617. doi: 10.1097/MOP.0000000000001077.
5
Anaphylaxis is a rare reaction in COVID-19 vaccination.
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):839-842. doi: 10.23812/BELLOMO_EDIT_3_21.
6
Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders.
Medicine (Baltimore). 2022 Jul 29;101(30):e29571. doi: 10.1097/MD.0000000000029571.
7
Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
JAMA Netw Open. 2021 Oct 1;4(10):e2131034. doi: 10.1001/jamanetworkopen.2021.31034.
8
Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
Vaccine. 2021 Jul 22;39(32):4407-4409. doi: 10.1016/j.vaccine.2021.06.058. Epub 2021 Jun 23.
9
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.
10
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
J Allergy Clin Immunol. 2023 Aug;152(2):309-325. doi: 10.1016/j.jaci.2023.05.019. Epub 2023 Jun 7.
引用本文的文献
1
SARS-CoV-2 Receptor Binding Domain (RBD) Protein-Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus Macaques.
Vaccines (Basel). 2025 Jun 17;13(6):648. doi: 10.3390/vaccines13060648.
2
Network analysis of adverse event patterns following immunization with mRNA COVID-19 vaccines: real-world data from the European pharmacovigilance database EudraVigilance.
Front Med (Lausanne). 2025 Feb 19;12:1501921. doi: 10.3389/fmed.2025.1501921. eCollection 2025.
3
Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination.
PLoS One. 2024 Dec 20;19(12):e0315499. doi: 10.1371/journal.pone.0315499. eCollection 2024.
4
mRNA vaccines for infectious diseases - advances, challenges and opportunities.
Nat Rev Drug Discov. 2024 Nov;23(11):838-861. doi: 10.1038/s41573-024-01042-y. Epub 2024 Oct 4.
5
Current landscape of mRNA technologies and delivery systems for new modality therapeutics.
J Biomed Sci. 2024 Sep 10;31(1):89. doi: 10.1186/s12929-024-01080-z.
6
Toxicologic Pathology Forum: mRNA Vaccine Safety-Separating Fact From Fiction.
Toxicol Pathol. 2024 Aug;52(6):333-342. doi: 10.1177/01926233241278298. Epub 2024 Sep 10.
7
Significant association between asthma and a lower risk of mortality among COVID-19 patients in Spain: A meta-analysis.
Qatar Med J. 2024 Jul 4;2024(3):34. doi: 10.5339/qmj.2024.34. eCollection 2024.
8
Preliminary Report of Nationwide COVID-19 Vaccine Compensation in Taiwan.
Healthcare (Basel). 2024 Jun 24;12(13):1250. doi: 10.3390/healthcare12131250.
9
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
10
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination.
J Allergy Clin Immunol. 2024 Jun;153(6):1634-1646. doi: 10.1016/j.jaci.2024.03.001. Epub 2024 Mar 7.
本文引用的文献
1
True, true, and unrelated: Stop routine testing to vaccine excipients for suspected vaccine allergy.
Ann Allergy Asthma Immunol. 2022 Jul;129(1):24-26. doi: 10.1016/j.anai.2022.04.007.
2
Allergy evaluation of messenger RNA vaccine reactions is crucial, with a specific role for polyethylene glycol testing.
Ann Allergy Asthma Immunol. 2022 Jul;129(1):22-23. doi: 10.1016/j.anai.2022.01.046.
3
We should abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis.
Ann Allergy Asthma Immunol. 2022 Jul;129(1):20-21. doi: 10.1016/j.anai.2022.01.016.
4
We should not abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis.
Ann Allergy Asthma Immunol. 2022 Jul;129(1):17-19. doi: 10.1016/j.anai.2022.01.040.
5
Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy.
J Allergy Clin Immunol. 2022 Jul;150(1):12-16. doi: 10.1016/j.jaci.2022.03.023. Epub 2022 Apr 7.
6
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later.
Ann Allergy Asthma Immunol. 2022 Jul;129(1):40-51. doi: 10.1016/j.anai.2022.03.030. Epub 2022 Apr 4.
7
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
JAMA Intern Med. 2022 Apr 1;182(4):376-385. doi: 10.1001/jamainternmed.2021.8515.
8
The adverse reactions to vaccines practice parameter 10 years on-what have we learned?
Ann Allergy Asthma Immunol. 2022 Jul;129(1):35-39. doi: 10.1016/j.anai.2022.01.026. Epub 2022 Jan 31.
9
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138. doi: 10.15585/mmwr.mm7104e2.
10
Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Jan 4;5(1):e2143955. doi: 10.1001/jamanetworkopen.2021.43955.
Zotero 插件